Skip to main content

CRISPR Editing of Human Embryos Approved in the U.K.

Preserving the distinction between research purposes and clinical applications, the Human Fertilisation and Embryology Authority (HFEA), a U.K. regulatory body, has approved the use of CRISPR gene editing on human embryos. The HFEA indicated that its approval was specific to an application tendered by researchers at the Francis Crick Institute, who could begin their work “within the next few months,” provided they also secure the approval of a local ethics body.

The Crick’s research, which will be led by Kathy Niakan, Ph.D., is aimed at understanding the genes human embryos need to develop successfully. Details of the prop
osed work appeared in September 2015, when the Crick researchers submitted their application to the HFEA.

"To provide further fundamental insights into early human development, we are proposing to test the function of genes using gene editing and transfection approaches that are currently permitted under the HFE Act 2008,” said Dr. Niakan at the time. “We also propose to use new methods based on CRIPSR/Cas9, which allows very specific alterations to be made to the genome. By applying more precise and efficient methods in our research we hope to require fewer embryos and be more successful than the other methods currently used.”

In response to the current announcement, Paul Nurse, Ph.D., director of the Crick, noted that Dr. Niakan's proposed research is “important for understanding how a healthy human embryo develops. It will enhance our understanding of IVF success rates,” he continued, “by looking at the very earliest stage of human development—one to seven days." During this stage of development, a single cell gives rise to around 250 cells. In the Crick’s investigations, development will be stopped at this point and the embryos destroyed.

In line with HFEA regulations, any donated embryos will be used for research purposes only and cannot be used in treatment. These embryos will be donated by patients who have given their informed consent to the donation of embryos that are surplus to their IVF treatment.

The current announcement follows HFEA deliberations that were detailed in the minutes of a meeting that took place on January 14. The minutes indicate the kinds of questions that were raised by proposed use of the CRISPR/Cas9 technique:

“One of the peer reviewers had suggested using alternative techniques for gene disruption, such as gene expression knock-down using RNA interference (shRNA), instead of CRISPR/Cas9,” the minutes read. “However the Committee was satisfied that CRISPR/Cas9 had, in other studies, produced results suggesting that it was a highly efficient and targeted method of gene disruption, potentially superior to other techniques that were available.”

The minutes also described the aims of the Crick’s research:

Determine the relationship between the cellular and molecular properties of human preimplantation embryos and human embryonic stem cell lines.
Establish defined, animal product–free conditions for the derivation of pluripotent human embryonic stem cell lines, ultimately leading to Good Manufacturing Practice–compatible approaches.
Establish and characterize human extraembryonic stem cell lines.
It is with respect to the first aim that the CRISPR technique is most directly relevant. This technique, the researchers say, will allow functionally testing of the requirement of human-specific genes during embryonic development.

“Our recently published RNA sequencing data demonstrate several genes and signaling pathways that are specifically expressed during human embryo development, compared with mouse,” the researchers indicated. “Many of our candidate regulatory genes are also expressed in [human embryonic stem cell (hESC)] lines. Therefore, gene-editing approaches will be optimized in hESC lines, prior to experiments using embryos. However, while we showed that hESC have a related gene expression state to the epiblast in the embryo, they are far from identical, which means that ultimately, we need to test the function of genes directly in the human embryo to determine if they are necessary for development.”

Initially, the Crick’s research will focus on the Oct4 regulatory factor, deficiencies of which are associated with the inability to generate embryonic stem cells in mice. According to the Crick team, there is evidence of temporal distinctions in the expression dynamics of OCT4/Oct4 between humans and mice. “It is therefore important to functionally test the requirement of factors such as OCT4 in human embryogenesis, to directly test conserved versus specific roles compared to the mouse,” say the researchers. “As OCT4 is likely to play a role, this gene will also serve as a first proof of concept.”

Following OCT4, the researchers will focus on human-specific epiblast enriched genes, such as KLF17, which the Crick team we recently identified. The Crick team also looks forward to investigating several human-specific factor, whose expression is absent in any of the pluripotent stem cell lines established to date, such as ARGFX.

Source: http://www.genengnews.com

Popular posts from this blog

Gene therapy treats all muscles in the body in muscular dystrophy dogs

Human clinical trials are next step..
Source: www.healthcare.uiowa.edu
Muscular dystrophy, which affects approximately 250,000 people in the U.S., occurs when damaged muscle tissue is replaced with fibrous, fatty or bony tissue and loses function. For years, scientists have searched for a way to successfully treat the most common form of the disease, Duchenne Muscular Dystrophy (DMD), which primarily affects boys. Now, a team of University of Missouri researchers have successfully treated dogs with DMD and say that human clinical trials are being planned in the next few years.

"This is the most common muscle disease in boys, and there is currently no effective therapy," said Dongsheng Duan, the study leader and the Margaret Proctor Mulligan Professor in Medical Research at the MU School of Medicine. "This discovery took our research team more than 10 years, but we believe we are on the cusp of having a treatment for the disease."

Patients with Duchenne muscular dyst…

Schizophrenia symptoms linked to features of brain's anatomy?

Roger Harris/Photo Researchers, ISM/Phototake Using advanced brain imaging, researchers have matched certain behavioral symptoms of schizophrenia to features of the brain's anatomy. The findings, at Washington University School of Medicine in St. Louis, could be a step toward improving diagnosis and treatment of schizophrenia.
The study, available online in the journal NeuroImage, will appear in print Oct. 15.

"By looking at the brain's anatomy, we've shown there are distinct subgroups of patients with a schizophrenia diagnosis that correlates with symptoms," said senior investigator C. Robert Cloninger, MD, PhD, the Wallace Renard Professor of Psychiatry and a professor of genetics. "This gives us a new way of thinking about the disease. We know that not all patients with schizophrenia have the same issues, and this helps us understand why."

The researchers evaluated scans taken with magnetic resonance imaging (MRI) and a technique called diffusion ten…

The Nobel Prize in Chemistry 2015 for "mechanistic studies of DNA repair".

The Royal Swedish Academy of Sciences has decided to award the Nobel Prize in Chemistry for 2015 to Tomas Lindahl Francis Crick Institute and Clare Hall Laboratory, Hertfordshire, UK
Paul Modrich Howard Hughes Medical Institute and Duke University School of Medicine, Durham, NC, USA &
Aziz Sancar University of North Carolina, Chapel Hill, NC, USA
“for Mechanistic Studies of DNA Repair"


The cells’ toolbox for DNA repair The Nobel Prize in Chemistry 2015 is awarded to Tomas Lindahl, Paul Modrich and Aziz Sancar for having mapped, at a molecular level, how cells repair damaged DNA and safeguard the genetic information. Their work has provided fundamental knowledge of how a living cell functions and is, for instance, used for the development of new cancer treatments.

Each day our DNA is damaged by UV radiation, free radicals and other carcinogenic substances, but even without such external attacks, a DNA molecule is inherently unstable. Thousands of spontaneous changes to a cell’s …